✦ LIBER ✦

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

✍ Scribed by R. Dallmann; P. Weyermann; C. Anklin; M. Boroff; K. Bray-French; B. Cardel; I. Courdier-Fruh; H. Deppe; J. Dubach-Powell; M. Erb; R. H. Haefeli; M. Henneböhle; H. Herzner; M. Hufschmid; D. L. Marks; S. Nordhoff; M. Papp; C. Rummey; G. Santos; F. Schärer; H. Siendt; M. Soeberdt; L. T. Sumanovski; M. Terinek; C. Mondadori; N. Güven; A. Feurer

Book ID: 107703875
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 320 KB
Volume: 2
Category: Article
ISSN: 2190-5991
DOI: 10.1007/s13539-011-0039-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P4-325: A potent selective brain penetra

P4-325: A potent selective brain penetrant and orally active 5-HT6 receptor antagonist SUVN-502 for the symptomatic treatment of Alzheimer's disease

✍ Nirogi, Ramakrishna; Jayarajan, Pradeep; Vishwakarma, Santosh; Abraham, Renny; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Pharmacological Characterization of MK-0

Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

✍ Salvatore, C. A.; Hershey, J. C.; Corcoran, H. A.; Fay, J. F.; Johnston, V. K.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 370 KB